Professor of Medical Oncology
Institution:
Christie NHS Foundation Trust
Professor Juan Valle
Professor of Medical Oncology at the University of Manchester
Precision-Panc Grantholder
Juan Valle holds a Chair in Medical Oncology at the University of Manchester (Division of Cancer Sciences, Faculty of Biology, Medicine and Health); part of the Manchester Academic Health Sciences Centre (MAHSC). He is based at The Christie NHS Foundation Trust within the Gastrointestinal Disease Group and treats cancers of the pancreas, liver and biliary tract, and neuroendocrine tumours (NETs). He is the head of The Christie European Neuroendocrine Tumour Society (ENETS) Centre of Excellence.
Professor Valle is a member of the following subgroups of the National Cancer Research Institute (NCRI) Upper GI Clinical Studies Group: hepatobiliary, pancreatic and neuroendocrine (which he chaired between 2013 and 2017). He is Secretary of the UK and Ireland NET Society (UKINETS); Chair of the EORTC Hepatobiliary Task Force; member of the EORTC Gastrointestinal Tract Cancer Group; the National Cancer Institute Hepatobiliary Task Force [USA]; and Vice-Chair of the Cholangiocarcinoma Foundation Medical Advisory Board [USA].
He has been awarded a number of grants for research leading to numerous publications and presentations as well as national and international meetings and is a peer-reviewer for a number of international medical journals and grant-awarding bodies.
He is a member of ASCO (American Society of Clinical Oncology), ESMO (European Society for Medical Oncology), UKI NETS (UK and Ireland Neuroendocrine Tumour Society) and ENETS (European Neuroendocrine Tumour Society).
Juan has been instrumental in the concept design of Precision-Panc. Alongside, Prof Andrew Biankin, Prof Jeff Evans and Prof Owen Samson, Juan is the co-lead for the Precision-Panc Master Protocol, he is a member of the molecular Multi-Disciplinary Team and sits on the Precision-Panc Steering Committee, Scientific Advisory Board, Trial Management Group as well as Chairing the Patient and Public Involvement for the programme of research.
